Filter
162
Text search:
EUROPEAN
ANTIBIOTIC
AWARENESS
DAY
Featured
Recommendations
16
New Publications
27
Language
Document type
Studies & Reports
52
No document type
47
Guidelines
33
Strategic & Response Plan
11
Manuals
9
Fact sheets
4
Training Material
3
Situation Updates
3
Countries / Regions
Western and Central Europe
10
India
7
Global
6
Ghana
4
Kenya
4
South Africa
4
Eastern Europe
4
Ethiopia
3
Uganda
3
Philippines
3
Africa
3
Nigeria
2
Zimbabwe
2
Nepal
2
Thailand
2
Namibia
2
North Macedonia
2
Western Pacific Region
2
Tajikistan
2
Burkina Faso
1
Congo, Democratic Republic of
1
South Sudan
1
Jordan
1
Zambia
1
Tanzania
1
Malawi
1
Sudan
1
Peru
1
Ukraine
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Latin America and the Carribbean
1
Eastern Europe and Central Asia
1
Asia
1
Laos
1
Qatar
1
Iran
1
Vietnam
1
Turkmenistan
1
Denmark
1
Belgium
1
Authors & Publishers
Publication Years
Category
Countries
38
Public Health
11
Clinical Guidelines
11
Key Resources
9
Women & Child Health
5
Toolboxes
AMR
72
TB
10
Pharmacy
8
Planetary Health
7
Conflict
6
NTDs
6
Caregiver
4
NCDs
4
HIV
3
Global Health Education
3
Ebola & Marburg
2
Cholera
2
Rapid Response
2
Specific Hazards
2
COVID-19
1
2.0 Rapid Response
1
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are
...
Accessed April 2014
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan
...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
Accessed Febr. 6, 2020
This policy brief aims to provide a review of the current progress on implementing the Burkina Faso national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implemen
...
Antimicrobial resistance (AMR) is a global public health crisis that resulted in 1.14 million deaths in 2021. According to the Institute for Health Metrics and Evaluation estimates, 96 416 of these deaths occurred in the World Health Organization (WHO) Eastern Mediterranean Region. All 22 countr
...
A regional guide for governments in Asia and the Pacific to review, update and develop policies to address antimicrobial resistance and antimicrobial use in animal production
This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in line with the
strategic objectives of the Glo
...
A manual for developing national action plans.This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in
...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G
...
This paper was developed to support AMR coordination committees and others tasked with addressing AMR at country level to do just that. Drawing on the published literature and the operational experience and expertise of different LMICs, the paper points to six key strategies for success and offers a
...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities
...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
